financetom
Business
financetom
/
Business
/
ArcelorMittal, Partners Launch Carbon Capture Pilot at Gent Plant in Belgium
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
ArcelorMittal, Partners Launch Carbon Capture Pilot at Gent Plant in Belgium
May 22, 2024 5:01 AM

07:44 AM EDT, 05/22/2024 (MT Newswires) -- ArcelorMittal ( MT ) and partners Mitsubishi Heavy Industries, BHP (BHP), and Mitsubishi Development have launched a pilot carbon capture unit at the ArcelorMittal Gent plant in Belgium, BHP said Wednesday.

The unit will operate for one to two years, testing the feasibility of capturing a significant portion of the plant's carbon dioxide emissions.

The trial will involve two phases. The first will capture 300 kilograms of carbon dioxide daily from blast furnace top gas, and the second will test carbon dioxide capture from the hot strip mill reheating furnace off-gases, which include coke gas, blast furnace gases, and natural gas, BHP said.

Shares of ArcelorMittal ( MT ) were down 1.6% in recent Wednesday premarket activity.

Price: 25.78, Change: -0.41, Percent Change: -1.57

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Honda Motor Partners With Amazon Web Services to Develop Software-Defined Vehicles
Honda Motor Partners With Amazon Web Services to Develop Software-Defined Vehicles
Jan 7, 2025
02:54 PM EST, 01/07/2025 (MT Newswires) -- Amazon.com's ( AMZN ) Amazon Web Services said Tuesday it is working with Honda Motor ( HMC ) to help the automaker build software-defined vehicles. The collaboration involves leveraging Amazon Web Services cloud computing, generative AI, and IoT capabilities along with Honda's ( HMC ) data lake to accelerate the development of digitally-enabled,...
Anteris Technologies Positioned To Capture 4%-5% Of US Transcatheter Valve Replacement Market By 2030: Analyst
Anteris Technologies Positioned To Capture 4%-5% Of US Transcatheter Valve Replacement Market By 2030: Analyst
Jan 7, 2025
Barclays analyst Matt Miksic initiated coverage on Anteris Technologies Global Corp. ( AVR ) with a Positive rating and a forecast of $22. The analyst notes that Anteris Technologies’ DurAVR valve system is expected to become the second balloon-expandable transcatheter valve replacement (BEV TAVR) system by 2028 Clinicians show a clear preference for BEV TAVR systems over self-expanding (SEV) systems...
FDA approves injectable version of Bristol Myers Squibb's cancer drug Opdivo
FDA approves injectable version of Bristol Myers Squibb's cancer drug Opdivo
Jan 7, 2025
(This Dec. 27 story has been corrected to say Opdivo Qvantig has been approved to treat most previously approved tumor indications, not all previously approved tumor indications, in paragraph 5) By Sneha S K and Sriparna Roy (Reuters) - The U.S. Food and Drug Administration said on Friday that it has approved an injectable version of Bristol Myers Squibb's blockbuster...
FDA approves injectable version of Bristol Myers Squibb's cancer drug Opdivo (Dec. 27)
FDA approves injectable version of Bristol Myers Squibb's cancer drug Opdivo (Dec. 27)
Jan 7, 2025
By Sneha S K and Sriparna Roy Dec 27 (Reuters) - The U.S. Food and Drug Administration said on Friday that it has approved an injectable version of Bristol Myers Squibb's ( BMY ) blockbuster cancer drug, Opdivo. Opdivo is part of a class of drugs called PD-1 inhibitors, which enhance the immune system's ability to fight cancer by removing...
Copyright 2023-2026 - www.financetom.com All Rights Reserved